AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2025
Mar 6, 2025
34491_dirs_2025-03-05_b3b08044-6380-4c7a-b429-f62053818662.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2025-03-03
Reporting Person: Kelly John Alexander (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-03 | Common Stock | M | 1702 | — | Acquired | 86256 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | Restricted Stock Units | $ | M | 1702 | Disposed | Common Stock (1702) | Direct |
Footnotes
F1: Represents the vesting of Restricted Stock Units ("RSUs") on March 3, 2025.
F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3: On March 3, 2022, the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 3, 2025.
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19